Decrease in Circulating Myeloid Dendritic Cell Precursors in Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 70-80

  Yilmaz, Atilla ^a   Weber, Jana ^a   Cicha, Iwona ^a   Stumpf, Christian ^a   Klein, Michael ^b   Raithel, Dieter ^b   Daniel, Werner G ^a   Garlichs, Christoph D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Nuremberg Clinic Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CAROTID ARTERY; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UNSTABLE ANGINA PECTORIS; VARIANT ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; C-REACTIVE PROTEIN; CAROTID STENOSIS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL COUNT; CORONARY ARTERIOSCLEROSIS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33745263694     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.078     Document Type: Article

References (53)

1. Blake G.J., and Ridker P.M. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 (2003) 37S-42S
2. Luc G., Bard J.M., Juhan-Vague I., et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. the PRIME study. Arterioscler Thromb Vasc Biol 23 (2003) 1255-1261
3. Daugherty A., Pure E., Delfel-Butteiger D., et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest 100 (1997) 1575-1580
4. Zhou X., Nicoletti A., Elhage R., and Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102 (2000) 2919-2922
5. Wallberg-Jonsson S., Ohman M.L., and Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24 (1997) 445-451
6. Sturfelt G., Eskilsson J., Nived O., Truedsson L., and Valind S. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 71 (1992) 216-223
7. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., and Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92 (1995) 3893-3897
8. Frostegard J., Wu R., Giscombe R., Holm G., Lefvert A.K., and Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 12 (1992) 461-467
9. Wick G., Perschinka H., and Millonig G. Atherosclerosis as an autoimmune disease. an update. Trends Immunol 22 (2001) 665-669
10. Shoenfeld Y., Sherer Y., and Harats D. Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 22 (2001) 293-295
11. Salonen J.T., Yla-Herttuala S., Yamamoto R., et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339 (1992) 883-887
12. Xu Q., Willeit J., Marosi M., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341 (1993) 255-259
13. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 (1988) 983-986
14. Kuo C.C., Gown A.M., Benditt E.P., and Grayston J.T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13 (1993) 1501-1504
15. Mayr M., Metzler B., Kiechl S., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99 (1999) 1560-1566
16. Xu Q., Dietrich H., Steiner H.J., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12 (1992) 789-799
17. George J., Afek A., Gilburd B., et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 98 (1998) 1108-1115
18. Harats D., Yacov N., Gilburd B., Shoenfeld Y., and George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 40 (2002) 1333-1338
19. Palinski W., Miller E., and Witztum J.L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92 (1995) 821-825
20. Zhou X., Caligiuri G., Hamsten A., Lefvert A.K., and Hansson G.K. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21 (2001) 108-114
21. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
22. Arpinati M., Chirumbolo G., Urbini B., Perrone G., Rondelli D., and Anasetti C. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol 11 (2003) 345-356
23. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4. three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165 (2000) 6037-6046
24. Ito T., Inaba M., Inaba K., et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 163 (1999) 1409-1419
25. Cederblad B., Blomberg S., Vallin H., Perers A., Alm G.V., and Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J Autoimmun 11 (1998) 465-470
26. Gill M.A., Blanco P., Arce E., Pascual V., Banchereau J., and Palucka A.K. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 63 (2002) 1172-1180
27. Ozaki Y., Amakawa R., Ito T., et al. Alteration of peripheral blood dendritic cells in patients with primary Sjogren's syndrome. Arthritis Rheum 44 (2001) 419-431
28. Ota M., Amakawa R., Uehira K., et al. Involvement of dendritic cells in sarcoidosis. Thorax 59 (2004) 408-413
29. Upham J.W., Denburg J.A., and O'Byrne P.M. Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 32 (2002) 818-823
30. Donaghy H., Pozniak A., Gazzard B., et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98 (2001) 2574-2576
31. Kunitani H., Shimizu Y., Murata H., Higuchi K., and Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 36 (2002) 734-741
32. Wertheimer A.M., Bakke A., and Rosen H.R. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40 (2004) 335-345
33. Duan X.Z., Zhuang H., Wang M., Li H.W., Liu J.C., and Wang F.S. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 20 (2005) 234-242
34. Ulsenheimer A., Gerlach J.T., Jung M.C., et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41 (2005) 643-651
35. Uehira K., Amakawa R., Ito T., et al. Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 105 (2002) 296-303
36. Waltner-Romen M., Falkensammer G., Rabl W., and Wick G. A previously unrecognized site of local accumulation of mononuclear cells. The vascular-associated lymphoid tissue. J Histochem Cytochem 46 (1998) 1347-1350
37. Millonig G., Niederegger H., Rabl W., et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 21 (2001) 503-508
38. Bobryshev Y.V., and Lord R.S. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 37 (1998) 799-810
39. Yilmaz A., Lochno M., Traeg F., et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176 (2004) 101-110
40. Cravens P.D., and Lipsky P.E. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 80 (2002) 497-505
41. Peiser M., Grutzkau A., Wanner R., and Kolde G. CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells. J Immunol Methods 279 (2003) 41-53
42. Luftl M., Feng A., Licha E., and Schuler G. Dendritic cells and apoptosis in mycosis fungoides. Br J Dermatol 147 (2002) 1171-1179
43. Dieu-Nosjean M.C., Massacrier C., Homey B., et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192 (2000) 705-718
44. Bobryshev Y.V. Dendritic cells in atherosclerosis. current status of the problem and clinical relevance. Eur Heart J 26 (2005) 1700-1704
45. McWilliam A.S., Nelson D., Thomas J.A., and Holt P.G. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 179 (1994) 1331-1336
46. Weis M., Schlichting C.L., Engleman E.G., and Cooke J.P. Endothelial determinants of dendritic cell adhesion and migration. new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22 (2002) 1817-1823
47. Skowasch D., Jabs A., Andrie R., Dinkelbach S., Luderitz B., and Bauriedel G. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc Res 60 (2003) 684-691
48. Penna G., Vulcano M., Sozzani S., and Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63 (2002) 1164-1171
49. Alderman C.J., Bunyard P.R., Chain B.M., Foreman J.C., Leake D.S., and Katz D.R. Effects of oxidized low density lipoprotein on dendritic cells. a possible immunoregulatory component of the atherogenic micro-environment?. Cardiovasc Res 55 (2002) 806-819
50. Coutant F., Agaugue S., Perrin-Cocon L., Andre P., and Lotteau V. Sensing environmental lipids by dendritic cell modulates its function. J Immunol 172 (2004) 54-60
51. Bobryshev Y.V., and Lord R.S. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J Vasc Surg 35 (2002) 368-375
52. Bobryshev Y.V., Cao W., Phoon M.C., et al. Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis 173 (2004) 185-195
53. Cao W., Bobryshev Y.V., Lord R.S., Oakley R.E., Lee S.H., and Lu J. Dendritic cells in the arterial wall express C1q. potential significance in atherogenesis. Cardiovasc Res 60 (2003) 175-186